Home » Stocks » 111, Inc.

111, Inc. (YI)

Stock Price: $6.38 USD 0.05 (0.79%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 512.28M
Revenue (ttm) 564.58M
Net Income (ttm) -71.37M
Shares Out 82.36M
EPS (ttm) -1.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $6.38
Previous Close $6.33
Change ($) 0.05
Change (%) 0.79%
Day's Open 6.33
Day's Range 6.16 - 6.66
Day's Volume 37,944
52-Week Range 2.29 - 8.70

More Stats

Market Cap 512.28M
Enterprise Value 430.96M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 82.36M
Float 23.68M
EPS (basic) n/a
EPS (diluted) -1.27
FCF / Share -0.93
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 61,337
Short Ratio 0.27
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 0.91
PB Ratio 5.37
Revenue 564.58M
Operating Income -70.50M
Net Income -71.37M
Free Cash Flow -76.03M
Net Cash 81.32M
Net Cash / Share 1.01
Gross Margin 4.18%
Operating Margin -12.49%
Profit Margin -12.60%
FCF Margin -13.47%
ROA -19.24%
ROE -57.58%
ROIC -151.00%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$11.86*
Low
11.9
Current: 6.38
High
11.9
Target: 11.86
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions CNY.

Financial Overview

Year2019201820172016
Revenue3,9521,786959874
Revenue Growth121.28%86.14%9.8%-
Gross Profit16510490.7777.61
Operating Income-494-400-254-364
Net Income-500-380-249-363
Shares Outstanding16499.4572.0072.00
Earnings Per Share-6.10-7.64-6.90-11.62
Operating Cash Flow-512-343-204-389
Capital Expenditures-19.85-14.34-6.74-5.07
Free Cash Flow-532-357-211-394
Cash & Equivalents7211,107461640
Total Debt152---
Net Cash / Debt5691,107461640
Assets1,6101,546763942
Liabilities836323201172
Book Value7771,224-946-692
Numbers in millions CNY, except per-share numbers.

Company Profile

Company Details

Full Name 111, Inc.
Country China
Employees 1,932
CEO Jun Ling Liu

Stock Information

Ticker Symbol YI
Stock Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Unique Identifier NASDAQ: YI

Description

111, Inc., through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2019, it operated 12 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Shanghai, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.